Anzeige
Mehr »
Login
Sonntag, 30.03.2025 Börsentäglich über 12.000 News von 696 internationalen Medien
Ad-hoc-Meldung: Gleich zu Wochenbeginn prozentual dreistellig? Der frühe Vogel…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DSSN | ISIN: US98985Y1082 | Ticker-Symbol: ZA8
Tradegate
28.03.25
08:00 Uhr
11,600 Euro
+0,100
+0,87 %
1-Jahres-Chart
ZYMEWORKS INC Chart 1 Jahr
5-Tage-Chart
ZYMEWORKS INC 5-Tage-Chart
RealtimeGeldBriefZeit
11,30011,50029.03.
11,40011,50028.03.

Aktuelle News zur ZYMEWORKS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiZymeworks Inc.: Zymeworks Announces Participation in Upcoming Investor Conferences202VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics...
► Artikel lesen
DiZymeworks Inc.: Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting354Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327...
► Artikel lesen
MoZymeworks Inc. verzeichnet Aktienkauf von 1,64 Millionen US-Dollar durch EcoR1 Capital2
11.03.Zymeworks stock price target raised to $13 at H.C. Wainwright3
10.03.Deep Dive Into Zymeworks Stock: Analyst Perspectives (4 Ratings)1
06.03.Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW2511
ZYMEWORKS Aktie jetzt für 0€ handeln
06.03.Stifel maintains Zymeworks stock Buy rating, $28 target1
06.03.Zymeworks pauses plans to launch one ADC into clinic in favor of another asset1
06.03.Citi raises Zymeworks stock price target to $19, maintains Buy2
05.03.Zymeworks GAAP EPS of -$0.31 misses by $0.24, revenue of $31.03M misses by $14.17M2
05.03.Zymeworks Inc.: Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results392First-in-human global studies initiated for ZW191, an antibody-drug conjugate (ADC) engineered to target folate receptor-? (FR?) and ZW171, a bispecific 2 + 1 T cell engager (TCE) targeting mesothelinAcceleration...
► Artikel lesen
05.03.Zymeworks Inc. - S-8, Securities to be offered to employees in employee benefit plans-
05.03.Zymeworks Inc. - 10-K, Annual Report1
05.03.Zymeworks Inc. - 8-K, Current Report1
26.02.Zymeworks achieves $14M milestone under GSK deal4
26.02.Zymeworks Receives $14 Million Cash Research Milestone Payment From GSK302LONDON (dpa-AFX) - Zymeworks Inc. (ZYME), Wednesday announced that the company has received a cash research milestone payment of $14 million from GSK plc (GSK) associated with a previous milestone.The...
► Artikel lesen
26.02.Zymeworks Inc.: Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration502VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics...
► Artikel lesen
25.02.Zymeworks Inc.: Zymeworks Announces Participation in Upcoming Investor Conferences198VANCOUVER, British Columbia, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics...
► Artikel lesen
18.02.Zymeworks Inc.: Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors2
18.02.Zymeworks Inc. - 8-K, Current Report-
Seite:  Weiter >>
72 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1